Insider Trading History of Harral William Iii

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Harral William Iii since 2005. The trader's CIK number is 1035220. At the time of the last reporting, Harral William Iii was the Director of Salix Pharmaceuticals Ltd. (stock ticker symbol SLXP). Also see all insider trading activities at Salix Pharmaceuticals Ltd.

Note that in the past HARRAL WILLIAM III also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at D Technologies Inc (CHP) by Harral William Iii

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 CHP 1,500 $13,260 0 $0 0 $0

Yearly summary of insider trading at Salix Pharmaceuticals Ltd (SLXP) by Harral William Iii

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 SLXP 14,500 $99,615 0 $0 0 $0
2006 SLXP 10,000 $123,450 0 $0 0 $0

Yearly summary of insider trading at Bryn Mawr Bank Corp (BMTC) by Harral William Iii

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 BMTC 0 $0 8,000 $168,016 8,000 $94,536


Insider trading activities at 3 companies by Harral William Iii:

1. D Technologies Inc (CHP)

2. Salix Pharmaceuticals Ltd (SLXP)

3. Bryn Mawr Bank Corp (BMTC)

Table 1. Insider trading of D Technologies Inc (CHP) by Harral William Iii

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-06-27 CHP Buy 1,500 8.84 13,260

Table 2. Insider trading of Salix Pharmaceuticals Ltd (SLXP) by Harral William Iii

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-05-09 SLXP Buy 14,500 6.87 99,615
2006-05-19 SLXP Buy 5,000 12.35 61,725
2006-05-19 SLXP Buy 5,000 12.35 61,725

Table 3. Insider trading of Bryn Mawr Bank Corp (BMTC) by Harral William Iii

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-02-02 BMTC Sale 8,000 21.00 168,016
2006-02-02 BMTC Option Ex 8,000 11.82 94,536

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harral William Iii (Director of Salix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.